Carboxypeptidase-mediated enhancement of nitric oxide production in rat lungs and microvascular endothelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 1 31-1, 2004, Pages

  Hadkar, Vaishali ^a   Sangsree, Sakonwun ^a   Vogel, Stephen M ^a   Brovkovych, Viktor ^a   Skidgel, Randal A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Carboxypeptidase D; Carboxypeptidase M; Inducible nitric oxide synthase; Interferon ; Lipopolysaccharide

Indexed keywords

2 MERCAPTOMETHYL 3 GUANIDINOETHYLTHIOPROPANOIC ACID; ARGININE; ARGININE DERIVATIVE; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE D; CARBOXYPEPTIDASE M; CYTOKINE; ENZYME INHIBITOR; FURYLACRYLOYLALANYLARGININE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LYSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CELL MEMBRANE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATION; ISOLATED LUNG; KINETICS; LUNG; MICROSENSOR; MICROVASCULAR ENDOTHELIUM CELL; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SENSOR;

ANIMALS; ARGININE; CARBOXYPEPTIDASE B; CELLS, CULTURED; DIPEPTIDES; ENDOTHELIUM, VASCULAR; HYDROLYSIS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; LUNG; MICROCIRCULATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PERFUSION; PULMONARY CIRCULATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 2942750329     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00346.2003     Document Type: Article

References (76)

1. Albina JE, Mills CD, Barbul A, Thirkill CE, Henry WLJ, Mastrofrancesco B, and Caldwell MD. Arginine metabolism in wounds. Am J Physiol Endocrinol Metab 254: E459-E467, 1988.
2. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, and Suter PM. The American-European Consensus Conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med 157: 1332-1347, 1998.
3. Barrett AJ, Rawlings ND, and Woessner JF. Handbook of Proteolytic Enzymes. London: Academic, 1998.
4. Beckman JS and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol Cell Physiol 271: C1424-C1437, 1996.
5. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
6. Brovkovych V, Stolarczyk E, Oman J, Tomboulian P, and Malinski T. Direct electrochemical measurement of nitric oxide in vascular endothelium. J Pharm Biomed Anal 19: 135-143, 1999.
7. Chodimella V, Skidgel RA, Krowiak EJ, and Murlas CG. Lung peptidases, including carboxypeptidase, modulate airway reactivity to intravenous bradykinin. Am Rev Respir Dis 144: 869-874, 1991.
8. Cirino G, Fiorucci S, and Sessa WC. Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol Sci 24: 91-95, 2003.
9. Closs EI, Scheld JS, Sharafi M, and Forstermann U. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol 57: 68-74, 2000.
10. Connelly L, Palacios-Callender M, Ameixa C, Moncada S, and Hobbs AJ. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. Immunol 166: 3873-3881, 2001.
11. Currie GA, Gyure L, and Cifuentes L. Microenvironmental arginine depletion by macrophages in vivo. Br J Cancer 39: 613-620, 1979.
12. 2+ activation and inhibitor binding of carboxypeptidase M at low pH. Similarity to carboxypeptidase H (enkephalin convertase). Biochem J 261: 289-291, 1989.
13. Ermert M, Ruppert C, Gunther A, Duncker HR, Seeger W, and Ermert L. Cell-specific nitric oxide synthase-isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab Invest 82: 425-441, 2002.
14. Fan J, Ye RD, and Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 281: L1037-L1050, 2001.
15. Feihl F, Waeber B, and Liaudet L. Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther 91: 179-213, 2001.
16. Furfine ES, Harmon MF, Paith JE, and Garvey EP. Selective inhibition of constitutive nitric oxide synthase by 1-NG-nitroarginine. Biochemistry 32: 8512-8517, 1993.
17. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJR, and Knowles RG. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272: 4959-4963, 1997.
18. Geiger M, Stone A, Mason SN, Oldham KT, and Guice KS. Differential nitric oxide production by microvascular and macrovascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 273: L275-L281, 1997.
19. Gill DJ, Low BC, and Grigor MR. Interleukin-1 beta and tumor necrosis factor-alpha stimulate the cat-2 gene of the L-arginine transporter in cultured vascular smooth muscle cells. J Biol Chem 271: 11280-11283, 1996.
20. Gotoh T and Mori M. Arginase 11 downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells. J Cell Biol 144: 427-434, 1999.
21. Gow AJ and Ischiropoulos H. Nitric oxide chemistry and cellular signaling. J Cell Physiol 187: 277-282, 2001.
22. Gross SS, Kilbourn RG, and Griffith OW. NO in septic shock: good, bad or ugly? Learning from iNOS knockouts. Trends Microbiol 4: 47-49, 1996.
23. Hadkar V and Skidgel RA. Carboxypeptidase D is up-regulated in RAW 264.7 macrophages and stimulates nitric oxide synthesis by cells in arginine-free medium. Mol Pharmacol 59: 1324-1332, 2001.
24. Hecker M, Sessa WC, Harris HJ, Anggard EE, and Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci USA 87: 8612-8616, 1990.
25. Ischiropoulos H, Zhu L, and Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 298: 446-451, 1992.
26. Kakuda DK, Sweet MJ, MacLeod CL, Hume DA, and Markovich D. CAT2-mediated L-arginine transport and nitric oxide production in activated acrophages. Biochem J 340: 549-553, 1999.
27. Kharitonov SA, Lubec G, Lubec B, Hjelm M, and Barnes PJ. L-arginine increases exhaled nitric oxide in normal human subjects. Clin Sci (Lond) 88: 135-139, 1995.
28. Kilbourn RG and Goldfarb RD. Can nitric oxide production be modulated by altering L-arginine levels? Crit Care Med 27: 2586-2587, 1999.
29. Knowles RG and Moncada S. Nitric oxide synthases in mammals. Biochem J 298: 249-258, 1994.
30. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, and Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 9: 371-377, 1993.
31. Kubes P. Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2: 235-244, 1995.
32. Kuroki K, Cheung R, Marion PL, and Ganem D. A cell surface protein that binds avian hepatitis B virus particles. J Virol 68: 2091-2096, 1994.
33. Lee RP, Wang D, Kao SJ, and Chen HI. The lung is the major site that produces nitric oxide to induce acute pulmonary oedema in endotoxin shock. Clin Exp Pharmacol Physiol 28: 315-320, 2001.
34. Liu SF, Ye X, and Malik AB. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 159: 3976-3983, 1997.
35. Lu YT, Liu SF, Mitchell JA, Malik AB, Hellewell PG, and Evans TW. The role of endogenous nitric oxide in modulating ischemia-reperfusion injury in the isolated, blood-perfused rat lung. Am J Respir Crit Care Med 157: 273-279, 1998.
36. Malinski T and Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358: 676-678, 1992.
37. Matata BM and Galinanes M. Peroxynitrite is an essential component of cytokine production mechanism in human monocytes through modulation of NF-kappaB DNA-binding activity. J Biol Chem 277: 2330-2335, 2001.
38. McDonald KK, Zharikov S, Block ER, and Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the arginine paradox. J Biol Chem 272: 31213-31216, 1997.
39. McGwire GB and Skidgel RA. Extracellular conversion of epidermal growth factor (EGF) to des-Arg53-EGF by carboxypeptidase M. J Biol Chem 270: 17154-17158, 1995.
40. McGwire GB, Tan F, Michel B, Rehli M, and Skidgel RA. Identification of a membrane-bound carboxypeptidase as the mammalian homolog of duck gp180, a hepatitis B virus-binding protein. Life Sci 60: 715-724, 1997.
41. Michel T and Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 100: 2146-2152, 1997.
42. Moncada S and Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9: 1319-1330, 1995.
43. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
44. Mori M and Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun 275: 715-719, 2000.
45. Nagae A, Abe M, Becker RP, Deddish PA, Skidgel RA, and Erdös EG. High concentration of carboxypeptidase M in lungs: presence of the enzyme in alveolar type I cells. Am J Respir Cell Mol Biol 9: 221-229, 1993.
46. Natanson C. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 120: 771-783, 1994.
47. Norris KA, Schrimpf JE, Flynn JL, and Morris SMJ. Enhancement of macrophage microbicidal activity: supplemental arginine and citrulline augment nitric oxide production in murine peritoneal macrophages and promote intracellular killing of Trypanosoma cruzi. Infect Immun 63: 2793-2796, 1995.
48. Nussler AK, Billiar TR, Liu ZZ, and Morris SMJ. Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production. J Biol Chem 269: 1257-1261, 1994.
49. Peng HB, Libby P, and Liao JK. Induction and stabilization of 1 kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 270: 14214-14219, 1995.
50. Plummer TH Jr and Kimmel MT. An improved spectrophotometric assay for human plasma carboxypeptidase N1. Anal Biochem 108: 348-353, 1980.
51. Plummer TH Jr and Ryan TJ. A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N. Biochem Biophys Res Commun 98: 448-454, 1981.
52. Sangsree S, Brovkovych V, Minshall RD, and Skidgel RA. Kininase 1-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists. Am J Physiol Heart Circ Physiol 284: H1959-H1968, 2003.
53. Schmal H, Shanley TP, Jones ML, Friedl HP, and Ward PA. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol 156: 1963-1972, 1996.
54. Simmons WW, Closs EI, Cunningham JM, Smith TW, and Kelly RA. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and NO production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem 271: 11694-11702, 1996.
55. Skidgel RA. Assays for arginine/lysine carboxypeptidases: carboxypeptidase H (E; enkephalin convertase), M and N. In: Methods in Neurosciences: Peptide Technology, edited by Conn PM. Orlando, FL: Academic, 1991, p. 373-385.
56. Skidgel RA. Basic carboxypeptidases: regulators of peptide hormone activity. Trends Pharmacol Sci 9: 299-304, 1988.
57. Skidgel RA. Structure and function of mammalian zinc carboxypeptidases. In: Zinc Metalloproteases in Health and Disease, edited by Hooper NM. London: Taylor and Francis, 1996, p. 241-283.
58. Skidgel RA and Erdös EG. Biochemistry of angiotensin converting enzyme. In: The Renitt-Angiotensin System, edited by Robertson JIS and Nicholls MG. London: Gower Medical, 1993, p. 10.11-10.10.
59. Skidgel RA and Erdös EG. Cellular carboxypeptidases. Immunol Rev 161: 129-141, 1998.
60. Skidgel RA, Gao XP, Brovkovych V, Rahman A, Jho D, Predescu S, Standiford TJ, and Malik AB. Nitric oxide stimulates macrophage inflammatory protein-2 expression in sepsis. J Immunol 169: 2093-2101, 2002.
61. Skidgel RA, Johnson AR, and Erdös EG. Hydrolysis of opioid hexapeptides by carboxypeptidase N. Presence of carboxypeptidase in cell membranes. Biochem Pharmacol 33: 3471-3478, 1984.
62. Song L and Fricker LD. Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary. J Biol Chem 270: 25007-25013, 1995.
63. Spiecker M, Peng HB, and Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 272: 30969-30974, 1997.
64. Stevens BR, Kakuda DK, Yu K, Waters M, Vo CB, and Raizada MK. Induced nitric oxide synthesis is dependent on induced alternatively spliced CAT-2 encoding L-arginine transport in brain astrocytes. J Biol Chem 271: 24017-24022, 1996.
65. Stuehr D, Pou S, and Rosen GM. Oxygen reduction by nitric-oxide synthases. J Biol Chem 276: 14533-14536, 2001.
66. Tan F, Deddish PA, and Skidgel RA. Human carboxypeptidase M. Methods Enzymol 248: 663-675, 1995.
67. Tasaka S, Hasegawa N, and Ishizaka A. Pharmacology of acute lung injury. Pulm Pharmacol Ther 15: 83-95, 2002.
68. Varlamov O and Fricker LD. Intracellular trafficking of metallocarboxypeptidase D in AtT-20 cells: localization to the trans-Golgi network and recycling from the cell surface. J Cell Sci 111: 877-885, 1998.
69. Vodovotz Y, Kwon NS, Pospischil M, Manning J, Paik J, and Nathan C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. J Immunol 152: 4110-4118, 1994.
70. Walpen S, Beck KF, Schaefer L, Raslik I, Eberhardt W, Schaefer RM, and Pfeilschifter J. Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J 15: 571-573, 2001.
71. Wang D, Wei J, Hsu K, Jau J, Lieu MW, Chao TJ, and Chen HI. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats. J Biomed Sci 6: 28-35, 1999.
72. Wang WW, Jenkinson CP, Griscavage JM, Kern RM, Arabolos NS, Byrns RE, Cederbaum SD, and Ignarro LJ. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun 210: 1009-1016, 1995.
73. Wink DA, Miranda KM, Espey MG, Pluta RM, Hewett SJ, Colton C, Vitek M, Feelisch M, and Grisham MB. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal 3: 203-213, 2001.
74. Wu G, Flynn NE, Flynn SP, Jolly CA, and Davis PK. Dietary protein or arginine deficiency impairs constitutive and inducible nitric oxide synthesis by young rats. J Nutr 129: 1347-1354, 1999.
75. Wu G and Morris SMJ. Arginine metabolism: nitric oxide and beyond. Biochem J 336: 1-17, 1998.
76. Zouki C, Jozsef L, Ouellet S, Paquette Y, and Filep JG. Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes. J Leukoc Biol 69: 815-824, 2001.